Panacea Biotec (NSE:PANACEABIO) ROCE % : -0.34% (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Panacea Biotec ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Panacea Biotec's annualized ROCE % for the quarter that ended in Dec. 2023 was -0.34%.

Panacea Biotec ROCE % Historical Data

The historical data trend for Panacea Biotec's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec ROCE % Chart

Panacea Biotec Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

19.73

0.27

4.85

190.44

1.73

Panacea Biotec Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															9.95	7.93	5.97	-2.92	-0.34

Panacea Biotec ROCE % Calculation

Panacea Biotec's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	166.08	/	( ( (17588.69 - 7763.67)	+	(12711.66 - 3318.31) )	/ 2 )
	=	166.08	/	( (9825.02	+	9393.35)	/ 2 )
	=	166.08	/	9609.185
	=	1.73 %

Panacea Biotec's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-32	/	( ( (12721.6 - 3318.3)	+	(0 - 0) )	/ 1 )
	=	-32	/	( ( 9403.3	+	0 )	/ 1 )
	=	-32	/	9403.3
	=	-0.34 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Panacea Biotec (NSE:PANACEABIO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Panacea Biotec ROCE % Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Panacea Biotec (NSE:PANACEABIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (NSE:PANACEABIO) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

531349:India

Address

Mathura Road, B-1 Extn./G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044

Website

https://www.panaceabiotec.com

Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec (NSE:PANACEABIO) Headlines

No Headlines